| ||||
| ||||
|
 Keeping you updated on Data Changes since 2010.
5/04/2012 • Hematopoietic Project home page
(Hematopoietic Manual and stand-alone Heme DB) 3/20/2012 RPOH is an integrated, user-friendly help system for cancer registrars and others who work with cancer data. Developed in support of CDC's National Program of Cancer Registries (NPCR), RPOH facilitates the abstraction of cancer cases by centralizing standard abstracting and coding manuals into one accessible, easy- to-use resource. The manuals within RPOH are cross-referenced, indexed, and context-linked, making the information readily available to the user, so RPOH can eliminate the need for printed manuals. The following manuals are included in this release: RPOH for 2012, corresponding to NAACCR version 12.2, is scheduled for release in spring of 2012. Updated Registry Plus Online Help Version 12.1 12/05/2011 Timeline for Implementation Contents of Release 12/01/2011 10/12/2011 This release combines Part I of the manual, both sections 1 and 2, with Part II, the schemas, into a single online help system with combined index and robust navigation. The content of Part I is identical to the content of the PDF version. The content of Part II (the schemas) is expanded to include additional extra tables not included in the PDF format, especially useful for those who do CS training or perform quality control of CS data. The HTML online help system combines an index for Parts I and II, includes full text searching capability, and has multiple navigation methods. HTML online help systems are familiar to most users. Online help appears in a browser window using the standard Microsoft HTML Help interface, with selected features enabled by third-party tools. 10/02/2011 10/3/2011 10/1/2011 9/29/2011 The MP/H manual has also been updated to include the new codes for Multiplicity Counter. 8/10/2011 7/29/2011 The Collaborative Stage (CS) Team is preparing for the next release of CS in Fall 2011. In the meantime, the CS team has developed a known issue document that can be useful when coding in CSv02.03. This document contains important information for a few schemas and fields where there is a known issue with CSv02.03 that will be resolved in the upcoming release. This document was created to let you know that we are aware of the issues you may be encountering with these few fields in CSv02.03 and they will be resolved in CSv02.04. Please take a moment to download or print this FAQ document as a reference to use when coding these fields. NCRA's printed product of CS version 02.03.02 is a completely new publication compared to CSv02. This new version entirely replaces any past CS version.
Updates to the current printed product: In Part IIa of the printed product, the “Tongue and Gum” tab includes the printed section of “C00M-C03M
MELANOMA LIP, TONGUE, GUM”. In Part IIc of the printed product, the “Lymphoma & Miscellaneous” tab includes the printed section
of “C76-C80, C42 LYMPHOMA, HEMATOPOIETIC, and MISCELLANEOUS”. The page numbers after page 47 in the “C76-C80, C42 LYMPHOMA, HEMATOPOIETIC, and MISCELLANEOUS” section
were published incorrectly; they should be sequential. You are invited to participate in the 2011 CS Reliability Study that will focus on the Collaborative Stage Data Collection System v0203. The 2011 CS Reliability Study will be testing 19 different schemas, which are divided into four different groups. Each group will have 8 schemas for a total of 10 cases. You will be asked to abstract one group of cases, with the option to complete a second group of cases. Group assignment will be determined by the Reliability website. Four optional practice cases will also be available to complete during the registration process prior to the opening of the study. Completion of all 10 study cases in your group is required. This way you will get the most out of the study. How to register for the new study? Once the study opens for registration and practice cases at 8am on Monday, August 29, 2011, you can logon to the SEER Reliability Website and use the Study selection drop down box at the top of the Home page and choose “New Study”. Once you select New Study, you will be brought to the Study Registration page with a drop down stating “Please choose study”. Use this drop down to select “2011 CS Reliability Study” and then press “Select Study”. Once the above step is completed, you will then be asked to verify your current institution. How to code the cases? Once you have successfully logged in and have registered for the 2011 CS Reliability Study, click on the Cases menu item on the left side of your screen. Choose either the Practice Cases or the Regular Cases menu item and follow the instructions in the User Guide section which will be displayed when you begin coding the cases on the SEER Reliability website. Questions? For further information, please contact Jennifer Ruhl or Lynda Douglas. 6/08/2011 View Issue-Decision Table. Read Part 1 of Issue-Decision Table (The Connection; winter 2010-2011, pgs 11-12). 4/29/2011 CSV02.03.02 Released! The January 2011 updated (released April 2011) of CS version 020302 have been posted. NCRA offers 2 printed products for your needs: 2/21/2011 Appendix C: Site Specific Coding Modules This one source is Appendix C of the SEER Program Code Manual. Appendix C was created to eliminate the use several manuals. The link to Appendix C is http://www.seer.cancer.gov/manuals/2010/appendixc.html. Organized by primary site, the website provides ONE SOURCE for the following references needed for abstracting SEER required cancer data - Coding Guidelines, for selected Primary Sites; MP/H Coding Rules: You select the format you prefer after clicking on this option; CS Staging Schemas; Surgery Codes. 1/17/2011 Update for Cancer Registrars-Collaborative Stage version 02.03.02 The Collaborative Stage Management Team wanted to be sure that the Cancer Registrar community was aware of some updates related to the status of CS version 02.03.02. • Cancer Registry Software Vendors were notified recently that the fourth production release of the Collaborative Stage Data Collection System (CS version 02.03.02) is now available. Each software vendor is responsible to communicate with their customers about their client software updates. Cancer Registries should look for communication directly from their software vendor or contact their software vendor directly with questions about client software updates. • Along with the shift to v.02.03.02 software; the schemas have also been updated. The CS web page (www.cancerstaging.org/cstage) has both 02.03.02 and the version 02.02 schemas posted. When your vendor updates your software to include the 02.03.02 revisions; Cancer Registrars should immediately begin using the 02.03.02 schemas. While your software is still operating with version 02.02; Cancer Registrars should only use the 02.02 schemas. The schemas for v.02.03.02 will be available in pdf format by the end of January 2011. • The General Rules (Part 1 Section 1) has also been updated for use with CS Version 02.03.02. However, do not use this version of the General Rules until you receive and install your software upgrade with CS version 02.03.02. • Updates to the Lab Tests, Tumor Markers, and Site-Specific Factor Notes (Part 1, Section 2) for use with CS Version 02.03.02 are currently underway and will be available on the CS web page by the end of January 2011. • The User Friendly Electronic CS Manual for version 02.03.02 will be released as an HTML Online Help product as well as a PDF. The HTML Online Help version is a single file that can be downloaded from the Web and installed on your desktop. It provides multiple navigation tools, including clickable table of contents and index, page-by-page navigation, and full-text searching. It contains numerous hyperlinks including links to schemas from Part I of the manual. Availability of this helpful tool is anticipated in February 2011. General questions related to CSv2 should be submitted to CSv2@facs.org. All medical, abstracting, coding, and staging questions should be submitted to the CAnswer Forum at http://cancerbulletin.facs.org/forums/. 11/11/2010 11/02/2010 [Per NAACCR's Listserv] The Collaborative Stage Project Management Team met in September and, given the challenges with implementing CS Version 2, determined that integration and implementation of Pre and Post Treatment Staging into the CS System be put on hold. The Team concluded that more research needs to be conducted on how to best capture these data, what needs to be collected, and under what circumstances. In addition, careful consideration needs to be given to minimizing the burden and maximizing the utility for such data collection if and when these data elements are defined and required. Therefore, we do not anticipate the addition of this component into the CS System in the near future. Additional questions can be directed to CSv2@facs.org. 10/20/2010 Version 1.6.1 of SEER’s Hematopoietic & Lymphoid Neoplasm Project was released October 20, 2010. The Hematopoietic and Lymphoid Neoplasm Case Reportability and Coding Manual is embedded in the Hematopoietic Database (Hematopoietic DB). This manual contains reportability instructions and rules for determining the number of primaries, the primary site and histology, and the cell lineage or phenotype. The manual also includes several appendices. Use the instructions and rules within the manual first. The Hematopoietic DB is used when the rules specifically instruct the abstractor to refer to the DB or when the registrar has used all of the rules in the manual. The Hematopoietic DB is an electronic tool developed to assist in screening for reportable cases and determining reportability requirements. The database contains abstracting and coding information for all hematopoietic and lymphoid neoplasms (9590/3-9992/3). 09/13/10 The changes fall into the following categories: The errata summaries are available in the following formats: Most of the identified problems are minor typos, such as printing "the the" when we meant "the." But some
are more serious errors that could cause misunderstanding or an error in staging or data collection. Content
changes that affect staging are few and include the following: Key points regarding the errata: View the complete errata, the summary tables, and printing instructions on the AJCC website. 07/08/10 [From the Collaborative Staging Website] The CSv2 Implementation Guide PDF was just updated. Documentation for the release versions of CSv2 is maintained on the Software Products for Collaborative Staging Version 2 (CSv2) webpage. 07/01/10 Sweeping Revisions for Cancer Registries [Journal of AHIMA] While updates to cancer registry commonly occur every few years, 2010 marks an unusually high number of changes to the field, according to Susan Koering, MEd, RHIA, CTR, president of the National Cancer Registrars Association and oncology registry manager at Park Nicollet Methodist Hospital–Frauenshuh Cancer Center, based in St. Louis Park, MN. Changes that registrars face in 2010 include:
Changes in cancer reporting requirements and standards announced by the American College of Surgeons Tightened cancer registry certification requirements “This is a massive change. It is a new way to look at how we are gathering our data,” says Laura Vondenhuevel, RHIT, CTR, the assistant tumor registrar at Wright-Patterson Medical Center, located at Wright- Patterson Air Force Base in Ohio. Vondenhuevel also facilitates the AHIMA cancer registry Community of Practice. “It is not just coding changes for us, it is also staging changes for the doctors. So it is a whole new ballgame.” Most of the changes begin with 2010 cases. But since many cancer registry units have a six-month delay in working on cases, the changes are expected to hit much of the industry in July... 06/22/10 Hematopoietic & Lymphoid Neoplasm Project [Version 1.6 released June 18, 2010] Version 1.6 of the Hematopoietic DB and the embedded Hematopoietic Manual are now available on the SEER website. The new version includes corrections to the Hemato DB and to the Manual, including the requested corrections to the flowcharts. A complete list of the corrections is attached and is also posted on the website. 06/07/10 [From the Collaborative Staging Website] Version 02.02.00. A new version of CSv2 software (version 02.02.00) was released on April 29, 2010. This release includes updates for issues detected by system tests and mapping refinements as requested by the CSv2 Mapping and IT teams. This version provides updates to the DLL, including all API calls, schemas, table attributes, systems documentation and sample programs. A new release of the CSv2 software (version 02.03.00) is planned for October 2010. This release will include updates resulting from the schema proofing and validation project currently underway. This release will also include updates scheduled for implementation in January 2011. Details on the specific updates included in this release will be documented and posted when the software is released. 05/20/10 [From the Collaborative Staging Website] SEER Abstract Addendum Generator for 2010 Cases Abstracted under Collaborative Stage version 1 (CSv1) released May 14, 2010. While the ideal situation is that all 2010+ cases are abstracted into Collaborative Staging version 2 (CSv2) software, some facilities/registries may need to abstract 2010+ cases before their abstracting software can be updated to CSv2. This tool lists the Collaborative Staging (CS) fields and space to abstract the information needed for CSv2. You must have Word 2003 or later on your computer to run this tool. See http://www.seer.cancer.gov/tools/absgenerator/ for more information. 05/13/10 [From the Collaborative Staging Website] Collaborative Stage Version 02.02.00 Release Announcement Contents of Release The new version includes corrections to the software and corresponding API documentation. Two new components have been added: VB source code and HTML documentation for schema selection. The function cstage_get_version was added to the EDITS interface. A blank in the field Lymph-Vascular Invasion will now be considered valid when the year of diagnosis is 2009 or earlier and CS Version Input Original is less than 020000. See the “Release Notes” and the file “Changes for CSv2.2.doc” for more details... Implementing Version 02.02.00 If you have not yet implemented CS version 02.00.01 (released in 01/10), or 02.01.00 (released in 2/10), you can implement this new release instead. Note that all conversion specifications and implementation instructions published for the initial version 2 release must still be followed. If you have implemented CS version 2 and converted your old data, but have not yet collected any new cases under CSv2, you can just replace the DLL with the new one and re-derive all stage data with the new version, setting the CS Version Derived to ‘020200’. If you have implemented CSv2, converted old data, and collected any new data under CSv2, you may also need to review some cases for which the schema selection algorithm may have returned an incorrect result. This new release includes a change in the handling of blanks in schema discriminator, Site-Specific Factor 25 (SSF25). The schema selection algorithm will no longer resolve to a schema when a discriminator is needed but is blank. Any cases matching the following sites and histologies and having a blank string in SSF25 should be reviewed. The blank string should be replaced with an appropriate non-blank code and all of the CS fields should be reviewed and recoded if necessary... Software The CSv2 teams are still resolving some outstanding issues. Revisions to existing content and new features will be announced on this page. Check back often to view news and updated content. Additionally, e- mail notifications will be sent to cancer registry professionals and vendors as updates for CSv2 products are released. In the meantime, CSv2 teams will continue their diligent efforts to provide the cancer registry community with the CSv2 products for 2010 implementation.... 05/04/10 [From the Collaborative Staging Website] Organization Recommendations and Requirements for Implementation of CS Version 02.00.01 Each standard-setting group has specific requirements and recommendations for implementation of CS Version 2. Click on the links below to download the individual requirements. Where necessary, refer to individual program or central cancer registry requirements for additional information.
04/29/10 [From the Collaborative Staging Website] Part II: Collaborative Staging and Coding Manual, Part II, version 02.02.00 (April 2010). PDF Schemas. These PDF files collectively incorporate Part II of the coding manual, and contain all the tables required to code CS version 2. 04/12/10 [From the CoC Flash] The year 2010 has brought many changes for the cancer registry. As we turn to the second quarter of 2010, activity is still brisk within the CSv2 teams. The purpose of this communication is to provide timely updates related to various CSv2 activities, including software releases, timelines, and future activities. The CSv2 Project Management Team met recently and underwent a process review session to determine what worked in the development of CSv2 and where things could be improved. Feedback received on the implementation of CSv2 was reviewed with the Project Management Team and all team leaders. A comprehensive plan for the ongoing maintenance of CSv2 is in development. Data Validation of Site-Specific Schema PDF Formatting of Site-Specific Schema Collection of Pre/Post Treatment Data Elements Informatics Team A new release (version 02.02.00) is planned for April 29, 2010. This release will include updates for issues detected by system tests and mapping refinements as requested by the Mapping and IT teams. Details on the specific updates included in this release will be documented and posted when the software is released. Lastly, a future release (version 02.03.00) is planned for late August 2010. This release will incorporate changes resulting from the data validation process mentioned above. 04/01/10 03/12/10 Version 1.4 of the Hematopoietic DB and the embedded Hematopoietic Manual are now available on the SEER website. The new version includes corrections to the Hemato DB and to the Manual, including the requested corrections to the flowcharts. A complete list of the corrections is also posted on the website. 03/01/10 CSv2 PART I Available for Download!
Part I, Section 1: General Rules [125 pgs] & Part I, Section 2: Lab Tests, Tumor Markers, and Site- Specific Factor Notes [130 pgs] PDFs. 02/18/10 Order past Webinars! Learn more @ Archived Webinars 02/04/10 Order past Webinars! Learn more @ Archived Webinars 01/14/10 The new version incorporates significant changes to collaborative staging that are effective for cases diagnosed on or after January 1, 2010, and are based on the American Joint Committee on Cancer's (AJCC) Cancer Staging Manual, 7th edition. Available at http://cancerstaging.org/cstage/index.html, CSv2 contains software programs and tools, general instructions and implementation guidelines, site-specific codes and coding instructions for the new variables, and standard-setter requirements. Cases diagnosed in 2010 must be coded using the revised version. Commission on Cancer (CoC)-accredited programs should install software updates before abstracting 2010 diagnoses. The CSv2 software will include new staging algorithms and will utilize the data elements as defined in the North American Association of Central Cancer Registries (NAACCR) Inc.?s Record Layout Standards, Volume II, Version 12. Registry software systems must incorporate the new CSv2 software. In addition, current registry data will need to be converted to the new CSv2 and NAACCR version 12 standards prior to using CSv2. Specifications for the data conversion will be available on the CS Web page. The Centers for Disease Control and Prevention will provide a program for the conversion of the staging data elements. If abstracting of 2010 cases begins before the software is updated, it will be necessary to review those cases after the update to code the new items and ensure that converted items have specific codes assigned. Electronic conversion of Class of Case and Race items may result in broader categories than the items require for 2010 cases. Cases diagnosed prior to 2010 may be coded using the new layout, but it is not necessary to code the items with a 2010 implementation date. To ensure correct conversion and derivation of CS data, all records in the registry database with staging information diagnosed from 1/1/2004 through the date of implementation must be processed through the CSv2 conversion algorithm. AJCC 6 stage and SS1977 and SS2000 will be re-derived on all cases where sufficient information is available. Registries are urged to identify all edits developed for use with CSv1 on the fields they collect and re-edit all cases before implementation of CSv2. CSv1 edits were added to the standard NAACCR metafile at intervals from 2004 through mid-2009; all CSv1 cases in the registry database may not have passed through all available CS edits. Users can expect fewer conversion problems with edited data. Once CSv2 is installed, it will be the only CS version used for all cases diagnosed from the year 2004 to the present, regardless of diagnosis year. The CSv2 algorithm for AJCC 6 and 7 will be applied to cases as described below: The CS Implementation Guide, CSv2 User Documentation, and other tools will provide detailed information to ensure a smooth transition from CSv1 to CSv2. These documents are also available on the CS Web page. Recommendations and Requirements for Implementation of CS Version 02.00.01 Vendor and general questions regarding the CS release can be submitted to CSv2@facs.org. All technical and coding questions should be submitted to the Inquiry and Response (I&R) System. Note: The CS Web pages have been redesigned for CSv2, and any bookmarks for pages within the Web site may need to be reset. 01/07/10 Order past Webinars! Learn more @ Archived Webinars 12/09/09 SEER announced the Hematopoietic Database (DB) is now available on the SEER website. The Hematopoietic and Lymphoid Neoplasm Case Reportability and Coding Manual is embedded in the Hematopoietic DB. The Manual can be accessed from the first screen of the Hematopoietic DB by clicking on the Hemato Manual button located on the lower-right of the screen. A total of 13 hematopoietic educational presentations will be available on the SEER website. There is no charge for the Hematopoietic DB, the manual, or any of the presentations. Download Hematopoietic DB with the embedded Manual. Main contact: NCISEERQI@mail.nih.gov. 12/08/09 NAACCR's 2010 Implementation Guidelines and Recommendations (For NAACCR Standards Volume II, Data Standards and Data Dictionary, Version 12, effective with cases diagnosed on or after January 1, 2010) have been released. They have been completed to the best of the ability of the work group. At the time the guidelines were released the materials for CSV2 and Hematopoietic MP/H Rules were not finalized; therefore, more detailed information could not be incorporated in to the guidelines. As updated information is received it will be shared with the NAACCR membership through the NAACCR listserv. Access NAACCR's 2010 Implementation Guidelines and Recommendations (PDF). 12/07/09 CSv2 Speakers Bureau members were trained to deliver presentations and case exercises that address the following sites included in version two of the Collaborative Stage Data Collection System. View Speakers
Bureau lists. 12/03/09 Pre-Order the Archived Webinars 11/23/09 Go to the Case Data Collection Site. (account required) 11/05/09 Pre-Order the Archived Webinars 10/22/09 Pre-Order the Archived Webinars 10/14/09 Considered the gold standard in cancer staging, the AJCC Cancer Staging Manual brings together the appropriate and evidence-based criteria for the staging of cancer for 52 anatomic primary sites, which includes the rational and rules for staging; the background explanation of the changes between the sixth and seventh editions; the definitions of tumor, lymph node involvement, and metastasis; stage groupings; and histologic grade. “The AJCC believes this newly released Edition of the AJCC Cancer Staging Manualwill enhance the utility of the TNM* staging to patients and clinicians,” said Stephen Edge, MD, FACS, the publication’s editor. “This seventh edition is also a springboard to the exciting future of personalized cancer care using data to more specifically define prognosis and the potential for benefit from specific therapies,” Dr. Edge said. Published by Springer, the manual, handbook, and atlas are all prepared by the AJCC in collaboration with its member organizations, including the American Cancer Society, which provided primary funding for the development. These organizations work with the AJCC in the promotion of staging at the time of diagnosis in order to achieve better patient outcomes. 10/08/09 Pre-Order the Archived Webinars 10/2/2009
09/24/09 Pre-Order the Archived Webinars 09/17/09
09/3/09 Pre-Order the Archived Webinars 09/2/09 TOPIC: Session Information: 2010 Cancer Data Collection Updates: Standards Volume II, Version 12. 09/01/09 Take the Online Survey. Survey deadline = 9/15/09 08/29/09 "Webinar series will provide educational opportunities that are accessible and cost appropriate...NCRA has been involved in understanding these changes to be fully prepared to ascertain and deliver on the educational needs of the members and greater cancer registry community." 8/15/2009
08/05/09 07/31/09 07/16/09 06/10/09 "Six activities need to be on every registrar's 2010 readiness action plan: 06/01/09 05/20/09 "NAACCR and standard setters in cancer surveillance chose to implement major changes every 3 years to hopefully lighten the load on registrars and give them time to get ready for the new guidelines. Some in the cancer registry field have expressed concerns about the bulk of the changes coming in 2010..." 4/01/2009 The latest revision of Collaborative Staging (CS) has provided an opportunity for many standards-setters, vendors, and other interested organizations to work together towards a new version of the Collaborative Staging that is compatible with the AJCC Cancer Staging Manual, 7th Edition. The AJCC manual will be published in summer 2009 and be effective with January 1, 2010, cancer cases. The Collaborative Staging system is a joint effort between all standards-setting agencies and organizations involved in cancer surveillance in North America. These include AJCC, CoC, CDC/NPCR, NCI/SEER, NCRA, NAACCR, and Canadian Council of Cancer Registries. Several teams are involved in creating the changes necessary for CSv2—read about them in detail below... Read full article...pages 1 & 4. 02/01/09 12/31/08 "Advances in cancer medicine necessitate changes in how cancer data is collected. Some of these changes include the study of new biomarkers or existing tests that have new prognostic meaning. Diagnostic workup will begin to include the new markers that guide treatment decisions resulting in prognostic changes. These biomarkers and other significant prognostic information will be incorporated into the Site-Specific Factors (SSFs) of Collaborative Staging Version 2 (CSv2). Cancer Registrars play an important role in collecting and reporting data vital to providing quality care, understanding incidence and mortality, and patterns of care and outcomes." Read full article...pages 16-17. 12/01/08 "Changes to The North American Association of Central Cancer Registries (NAACCR) record layout that will affect coding and abstracting for the year 2010 are being developed. Several years ago, national standard setters for cancer surveillance agreed major changes needed to be curtailed to once every 3 years. This was to allow for all the difficulties in making programmatic changes, education to learn new standards, labor costs, etc. We are now preparing for our first 3-year cycle when major changes can happen. Consequently, we have 3 major changes happening at one time."
Tips on news &/or resources to be shared? Contact NCRA's Advocacy & Technical Practice Directors.
|
